BlackRock Japan’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

BlackRock Japan’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-998	Closed	-$11K	–	1449
2016 Q2	$11K	Buy	+998	New	+$12.7K	﹤0.01%	1268
2016 Q1	–	Sell	-893	Closed	-$17K	–	1494
2015 Q4	$17K	Sell	893 -139	-13%	-$3.02K	﹤0.01%	1194
2015 Q3	$19K	Buy	+1,032	New	+$17.5K	﹤0.01%	1099
2015 Q2	–	Sell	-2,663	Closed	-$40K	–	1414
2015 Q1	$40K	Sell	2,663 -805	-23%	-$11.2K	﹤0.01%	1099
2014 Q4	$46K	Buy	3,468 +947	+38%	+$12.2K	﹤0.01%	1110
2014 Q3	$32K	Buy	2,521 +611	+32%	+$5.93K	﹤0.01%	1111
2014 Q2	$19K	Buy	+1,910	New	+$18.4K	﹤0.01%	1157

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Japan's CNCE Position: Q3 2016 in Review

BlackRock Japan sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2016, closing a stake of 998 shares — an estimated $11K sold.

BlackRock Japan first reported a position in CNCE in Q2 2014 and held it in 7 quarters. The position peaked at $46K in Q4 2014. 94 funds tracked by Wall St. Rank hold CNCE as of Q3 2016.

BlackRock Japan reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
BlackRock Japan sold 998 Concert Pharmaceuticals, Inc. shares in Q3 2016, an estimated $11K.
BlackRock Japan first reported a position in Concert Pharmaceuticals, Inc. in Q2 2014 and held it in 7 quarters.
BlackRock Japan's Concert Pharmaceuticals, Inc. position peaked at $46K in Q4 2014.
94 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.